Acadia Pharmaceuticals reported $11.85M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 11.85M 1.09M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Aptinyx Inc APTX:US $ 2.11M 354K
Biogen BIIB:US $ 434.8M 36.1M
Bristol Myers Squibb BMY:US $ 2882M 62M
Cara Therapeutics CARA:US $ 9.74M 4.15M
Corcept Therapeutics CORT:US $ 8.25M 1.02M
Cytokinetics CYTK:US $ 14.08M 5.76M
Eisai 4523:JP Y 96106M 66475M
Eli Lilly And LLY:US $ 1659.3M 226M
Intercept Pharmaceuticals ICPT:US $ 11.67M 1.28M
Intra Cellular Therapies ITCI:US $ 10.75M 0.9M
Marinus Pharmaceuticals MRNS:US $ 3.3M 1.37M
Moderna Inc MRNA:US 181M 18M
Prothena PRTA:US 7.55M 1.76M
Ptc Therapeutics PTCT:US $ 22.88M 4.52M
Sarepta Therapeutics SRPT:US $ 56.21M 2.2M
Seattle Genetics SGEN:US $ 128.87M 41.64M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
Vanda Pharmaceuticals VNDA:US $ 5.55M 0.45M
Vertex Pharmaceuticals VRTX:US $ 198M 24.4M
YTE INCY:US $ 194.77M 42.22M